Treatment of Dupuytren's disease with collagenase
US5589171A · kind A · utility
28Cited by
8References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 22, 1994 |
| Grant date | Dec 31, 1996 |
| Priority date | — |
| Expiry date | Aug 22, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/4886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dupuytren's disease is treated by applying collagenase to the affected palmar fascia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.